Wednesday 10th November 2021
6:00pm - 7:00pm
This webinar will provide attendees with an update regarding shingles epidemiology and current trends in vaccination rates.
Low shingles vaccination rates in Australian adults impact the epidemiology of the disease. This webinar will explore what current guidelines advise regarding improving pertussis vaccination rates in Australia, and therefore reducing disease burden and complications.
It will discuss the two shingles vaccinations available in Australia, comparing efficacy, safety, dosage regimens and indications for each vaccine.
Accredited with RACGP (305628) & ACRRM (24536)
- describe the epidemiology of shingles in various population groups, including persons aged over 65 years
- outline current vaccination rates in older Australians, and recognised strategies for improving uptake of shingles vaccines
- explain the possible clinical sequelae associated with shingles, including serious complications, impact on quality of life, and the particular risk attributed to persons aged over 80 years
- identify the patients in whom shingles vaccination is a priority, based on age and medical comorbidities
- describe and compare the two shingles vaccines currently available in Australia, including safety profiles, efficacy, dosage regimens and costs.